Nabil Mehta, MD
Orthopaedic Surgery · Durham, NCNPI 1912490756
Payments from drug & device makers
Across 93 payments — averaging $157.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Encore Medical, LP$5K
- Medwest Associates$4K
- Stryker$4K
- Medical Device Business Services, Inc.$456
- Johnson & Johnson$422
- Tricoast Surgical Solutions LLC$236
- plus $343 from 6 others
What the payments were for
- Consulting fees$1,50010%
- Travel & lodging$4,61932%
- Food & beverage$4,38730%
- Education$4,13728%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Encore Medical, LP | 13 | $4,819 |
| Medwest Associates | 8 | $4,190 |
| Stryker | 40 | $4,176 |
| Medical Device Business Services, Inc. | 7 | $456 |
| Johnson & Johnson | 6 | $422 |
| Tricoast Surgical Solutions LLC | 13 | $236 |
| Zimmer Biomet | 1 | $168 |
| Smith+Nephew | 1 | $69 |
| Paladin Technology Solutions | 1 | $40 |
| Restor3d, Inc. | 1 | $29 |
| Arthrosurface Incorporated | 1 | $22 |
| Prytime Medical Devices, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DJO SURGICAL$9,190
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$2,130
- MAKO$326
- INHANCE$309
- AEQUALIS PERFORM REVERSED$301
- Vital$168
- AEQUALIS FLEX REVIVE$128
- FIBERGRAFT BG Morsels$118
- VIPER$118
- AXSOS$116
How this compares
$14,643 in reported general payments places this provider in the 70th percentile of 845 orthopaedic surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 29 | $76 |
| Tramadol Hcl | 15 | $14 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Durham
- William JiranekDurham$6.4M
- Thomas VailDurham$5.7M
- Mark EasleyDurham$4.2M
- Samuel AdamsDurham$3.3M
- Michael BolognesiDurham$2.5M
- Christopher BrownDurham$2.3M
- David MusanteDurham$2.2M
- James NunleyDurham$1.7M
- Samuel WellmanDurham$1.3M
- James DeorioDurham$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.